Audit 310831

FY End
2023-12-31
Total Expended
$32.42M
Findings
0
Programs
33
Organization: Institute for Systems Biology (WA)
Year: 2023 Accepted: 2024-06-28
Auditor: Clark Nuber P S

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.397 Cancer Centers Support Grants $2.15M Yes 0
93.172 Human Genome Research $1.96M Yes 0
93.RD Cancer Genomics Cloud Resource $1.60M Yes 0
81.RD Experimental Design, Implementation $1.07M Yes 0
93.353 21st Century Cures Act - Beau Biden Cancer Moonshot $544,826 Yes 0
93.350 National Center for Advancing Translational Sciences $396,514 Yes 0
93.838 Lung Diseases Research $379,949 Yes 0
12.RD Global Proteomic Analysis $277,021 Yes 0
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $261,600 Yes 0
12.RD Advancing Precision Psychiatry $220,172 Yes 0
47.074 Biological Sciences $210,595 Yes 0
93.RD Systems Biology of Influenza Virus Infection and Vaccination $200,010 Yes 0
81.049 Office of Science Financial Assistance Program $184,246 Yes 0
12.431 Basic Scientific Research $158,241 Yes 0
93.310 Trans-Nih Research Support $107,100 Yes 0
93.837 Cardiovascular Diseases Research $102,857 Yes 0
93.866 Aging Research $97,607 Yes 0
93.121 Oral Diseases and Disorders Research $89,894 Yes 0
93.859 Biomedical Research and Research Training $64,574 Yes 0
93.855 Allergy, Immunology and Transplantation Research $60,131 Yes 0
93.846 Arthritis, Musculoskeletal and Skin Diseases Research $47,856 Yes 0
93.839 Blood Diseases and Resources Research $46,079 Yes 0
47.078 Polar Programs $32,880 Yes 0
12.420 Military Medical Research and Development $31,705 Yes 0
93.865 Child Health and Human Development Extramural Research $20,749 Yes 0
93.396 Cancer Biology Research $20,164 Yes 0
12.RD Mircrorna Biomarkers of Cumulative $16,275 Yes 0
47.050 Geosciences $15,812 Yes 0
93.394 Cancer Detection and Diagnosis Research $13,594 Yes 0
93.398 Cancer Research Manpower $6,254 Yes 0
47.084 Nsf Technology, Innovation, and Partnerships $3,356 Yes 0
93.393 Cancer Cause and Prevention Research $1,379 Yes 0
12.RD Inflammatory Mediators Testing $1,275 Yes 0

Contacts

Name Title Type
SMK9PCMKXED6 Gary Streicher Auditee
2067321227 Vincent Stevens Auditor
No contacts on file

Notes to SEFA

Title: Note 1 - Method of Accounting Accounting Policies: Note 2 - Significant Accounting Policies Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. The Institute has elected not to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance. Negative amounts shown on the Schedule represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. De Minimis Rate Used: N Rate Explanation: The Institute has elected not to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance. The accompanying schedule of expenditures of federal awards (the "Schedule") includes the federal award activity of the Institute for Systems Biology (the Institute) under programs of the federal government for the year ended December 31, 2023. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of the Institute, it is not intended to and does not present the financial position, changes in net assets or cash flows of the Institute.
Title: Note 2 - Significant Accounting Policies Accounting Policies: Note 2 - Significant Accounting Policies Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. The Institute has elected not to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance. Negative amounts shown on the Schedule represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. De Minimis Rate Used: N Rate Explanation: The Institute has elected not to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance. Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. The Institute has elected not to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance. Negative amounts shown on the Schedule represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years.